Logo image of SGHT

SIGHT SCIENCES INC (SGHT) Stock Fundamental Analysis

NASDAQ:SGHT - Nasdaq - US82657M1053 - Common Stock - Currency: USD

4.21  +0.05 (+1.2%)

After market: 4.21 0 (0%)

Fundamental Rating

3

Overall SGHT gets a fundamental rating of 3 out of 10. We evaluated SGHT against 187 industry peers in the Health Care Equipment & Supplies industry. SGHT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SGHT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SGHT had negative earnings in the past year.
SGHT had a negative operating cash flow in the past year.
In the past 5 years SGHT always reported negative net income.
In the past 5 years SGHT always reported negative operating cash flow.
SGHT Yearly Net Income VS EBIT VS OCF VS FCFSGHT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -38.09%, SGHT is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
SGHT has a Return On Equity of -63.63%. This is comparable to the rest of the industry: SGHT outperforms 44.38% of its industry peers.
Industry RankSector Rank
ROA -38.09%
ROE -63.63%
ROIC N/A
ROA(3y)-36.62%
ROA(5y)-36%
ROE(3y)-52.97%
ROE(5y)-61.55%
ROIC(3y)N/A
ROIC(5y)N/A
SGHT Yearly ROA, ROE, ROICSGHT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

SGHT has a better Gross Margin (85.66%) than 96.79% of its industry peers.
In the last couple of years the Gross Margin of SGHT has grown nicely.
SGHT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y3.51%
SGHT Yearly Profit, Operating, Gross MarginsSGHT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

SGHT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SGHT has more shares outstanding
Compared to 5 years ago, SGHT has more shares outstanding
The debt/assets ratio for SGHT is higher compared to a year ago.
SGHT Yearly Shares OutstandingSGHT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SGHT Yearly Total Debt VS Total AssetsSGHT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

SGHT has an Altman-Z score of -0.98. This is a bad value and indicates that SGHT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.98, SGHT is not doing good in the industry: 62.57% of the companies in the same industry are doing better.
SGHT has a Debt/Equity ratio of 0.51. This is a neutral value indicating SGHT is somewhat dependend on debt financing.
SGHT's Debt to Equity ratio of 0.51 is in line compared to the rest of the industry. SGHT outperforms 40.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF N/A
Altman-Z -0.98
ROIC/WACCN/A
WACC9.02%
SGHT Yearly LT Debt VS Equity VS FCFSGHT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

SGHT has a Current Ratio of 10.47. This indicates that SGHT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 10.47, SGHT belongs to the top of the industry, outperforming 93.05% of the companies in the same industry.
SGHT has a Quick Ratio of 9.99. This indicates that SGHT is financially healthy and has no problem in meeting its short term obligations.
SGHT's Quick ratio of 9.99 is amongst the best of the industry. SGHT outperforms 93.05% of its industry peers.
Industry RankSector Rank
Current Ratio 10.47
Quick Ratio 9.99
SGHT Yearly Current Assets VS Current LiabilitesSGHT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

SGHT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.50%, which is quite good.
SGHT shows a decrease in Revenue. In the last year, the revenue decreased by -4.16%.
Measured over the past years, SGHT shows a very strong growth in Revenue. The Revenue has been growing by 27.88% on average per year.
EPS 1Y (TTM)12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.15%
Revenue 1Y (TTM)-4.16%
Revenue growth 3Y17.72%
Revenue growth 5Y27.88%
Sales Q2Q%-9.12%

3.2 Future

Based on estimates for the next years, SGHT will show a small growth in Earnings Per Share. The EPS will grow by 4.83% on average per year.
The Revenue is expected to grow by 8.42% on average over the next years. This is quite good.
EPS Next Y-14.03%
EPS Next 2Y3.97%
EPS Next 3Y7.94%
EPS Next 5Y4.83%
Revenue Next Year-9.73%
Revenue Next 2Y0.37%
Revenue Next 3Y4.37%
Revenue Next 5Y8.42%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SGHT Yearly Revenue VS EstimatesSGHT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
SGHT Yearly EPS VS EstimatesSGHT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGHT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SGHT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SGHT Price Earnings VS Forward Price EarningsSGHT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SGHT Per share dataSGHT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.97%
EPS Next 3Y7.94%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SGHT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SIGHT SCIENCES INC

NASDAQ:SGHT (7/3/2025, 8:08:54 PM)

After market: 4.21 0 (0%)

4.21

+0.05 (+1.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners50.88%
Inst Owner Change-7.06%
Ins Owners19.32%
Ins Owner Change8.83%
Market Cap217.66M
Analysts74.29
Price Target3.84 (-8.79%)
Short Float %2.78%
Short Ratio6.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.03%
Min EPS beat(2)-10.81%
Max EPS beat(2)2.74%
EPS beat(4)2
Avg EPS beat(4)1.31%
Min EPS beat(4)-10.81%
Max EPS beat(4)17.2%
EPS beat(8)5
Avg EPS beat(8)6.3%
EPS beat(12)8
Avg EPS beat(12)5.51%
EPS beat(16)9
Avg EPS beat(16)2.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-5.54%
Max Revenue beat(2)3.95%
Revenue beat(4)1
Avg Revenue beat(4)-1.64%
Min Revenue beat(4)-5.54%
Max Revenue beat(4)3.95%
Revenue beat(8)3
Avg Revenue beat(8)-1.65%
Revenue beat(12)5
Avg Revenue beat(12)-0.71%
Revenue beat(16)8
Avg Revenue beat(16)0.4%
PT rev (1m)10.24%
PT rev (3m)7.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.16%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-10.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.79
P/FCF N/A
P/OCF N/A
P/B 2.8
P/tB 2.8
EV/EBITDA N/A
EPS(TTM)-0.98
EYN/A
EPS(NY)-0.95
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS1.51
BVpS1.5
TBVpS1.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.09%
ROE -63.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.66%
FCFM N/A
ROA(3y)-36.62%
ROA(5y)-36%
ROE(3y)-52.97%
ROE(5y)-61.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y3.51%
F-Score2
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 40.06%
Cap/Sales 0.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.47
Quick Ratio 9.99
Altman-Z -0.98
F-Score2
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)106.51%
Cap/Depr(5y)124.16%
Cap/Sales(3y)0.94%
Cap/Sales(5y)1.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.15%
EPS Next Y-14.03%
EPS Next 2Y3.97%
EPS Next 3Y7.94%
EPS Next 5Y4.83%
Revenue 1Y (TTM)-4.16%
Revenue growth 3Y17.72%
Revenue growth 5Y27.88%
Sales Q2Q%-9.12%
Revenue Next Year-9.73%
Revenue Next 2Y0.37%
Revenue Next 3Y4.37%
Revenue Next 5Y8.42%
EBIT growth 1Y8.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year9.34%
EBIT Next 3Y12.11%
EBIT Next 5YN/A
FCF growth 1Y66.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.14%
OCF growth 3YN/A
OCF growth 5YN/A